A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pomalidomide Impurity 25 - Request Quote

Picture of Pomalidomide Impurity 25

Pomalidomide Impurity 25

SZ CAT No:SZ-P055045
CAS No
NA
Mol.F.
C16H8N2O5
Mol.Wt.
308.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Pomalidomide Impurity 25 is chemically 4-Amino-2-(1,3-dioxo-1,3-dihydroisobenzofuran-5-yl)isoindoline-1,3-dione. Pomalidomide Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Pomalidomide Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pomalidomide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Pomalidomide Impurity 25

Purchase Pomalidomide Impurity 25

Pomalidomide Impurity 25 suppliers

Pomalidomide Impurity 25 manufacturers

Pomalidomide Impurity 25 price

Order Pomalidomide Impurity 25

Enquire Pomalidomide Impurity 25

Pomalidomide Impurity 25 cost

Pomalidomide Impurity 25 Supplier

Pomalidomide Impurity 25 Distributor

Pomalidomide Impurity 25 for Method Validation

Pomalidomide Reference Standard

Pomalidomide Impurity 25 for ANDA Filing

Pomalidomide Impurity 25 for Forced Degradation Studies

Pomalidomide Impurity 25 Identification Standards

Pomalidomide Impurity 25 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,